Late-phase trials of targeted therapies for elevated lipoprotein(a) are nearing completion, with the first readouts expected ...
Allison Baum Gates: What has surprised you the most about how venture capital has changed in 2020? Laura Thompson: I was very surprised about the post-COVID market. What really shocked me from an LP ...